Ardelyx
ARDX
$6.42
Share price
1.74%
Change (1 day)
42.04%
Change (1 year)
Categories
P/S ratio for Ardelyx (ARDX)
P/S ratio as of April 2024 (TTM): 12.0
According to Ardelyx's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 12.0217. At the end of 2023 the company had a P/S ratio of 11.6.
P/S ratio history for Ardelyx from 2014 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 11.6 | 12.9% |
| 2022 | 10.2 | -16.6% |
| 2021 | 12.3 | -84.64% |
| 2020 | 80.0 | -36.63% |
| 2019 | 126 | 194.05% |
| 2018 | 42.9 | 474.64% |
| 2017 | 7.47 | |
| 2016 | N/A | -100% |
| 2015 | 19.6 | 76.35% |
| 2014 | 11.1 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | 4.65 | -61.31% | 🇺🇸 USA |
 Amgen AMGN | 5.14 | -57.27% | 🇺🇸 USA |
 Sanofi SNY | 2.44 | -79.71% | 🇫🇷 France |
 AstraZeneca AZN | 5.09 | -57.68% | 🇬🇧 UK |
 OPKO Health
OPK | 1.02 | -91.54% | 🇺🇸 USA |